Journal
/
/
Berigelse for kemoterapi kræft i æggestokkene stamceller fra humane cellelinier
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
DOI:

11:50 min

September 10, 2014

, , ,

Chapters

  • 00:05Title
  • 02:02Cell Culture and Fluorescent Labeling Ovarian Cancer Cell Lines
  • 03:39Enrichment for Cancer Stem Cells
  • 04:51CSC Characterization via Gene Expression Analysis for Stem Cell Markers
  • 06:10Analyzing CSCs for Cell Surface Markers CD117 and CD133
  • 07:42Analyzing CSCs for Therapeutic Response
  • 08:41Results: Validation of Ovarian CSCs Enrichment
  • 10:46Conclusion

Summary

Automatic Translation

Kræft stamceller (CSCS) er impliceret i tumor tilbagefald på grund kemoterapiresistens. Vi har optimeret en protokol for udvælgelse og udvidelse af CSCS fra ovariekræft cellelinjer. Ved at behandle celler med det kemoterapeutiske cisplatin og dyrkning i en stamcelle fremme medier vi berige for ikke-adhærente CSC kulturer.

Related Videos

Read Article